MENTHOLA SMITH: Open Payments
NPI 1558987990 · BIRMINGHAM, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,323 in 48 payments from 13 companies in 2025. Trend: 2023 $892 · 2024 $1,202 · 2025 $1,323
Food & beverage: $1,323
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 10 | $376 |
| PFIZER INC. | 5 | $268 |
| GlaxoSmithKline, LLC. | 9 | $262 |
| Dexcom, Inc. | 8 | $150 |
| Lilly USA, LLC | 7 | $113 |
| Amgen Inc. | 2 | $38 |
| Antares Pharma, Inc. | 1 | $21 |
| Exact Sciences Corporation | 1 | $18 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $17 |
| Sumitomo Pharma America, Inc. | 1 | $16 |
Products named: PREVNAR 20, Ozempic, Dexcom G6 Transmitter, Wegovy, SHINGRIX, TRELEGY ELLIPTA, MOUNJARO, KRYSTEXXA.
Industry payments across AL — which companies pay providers there.
